Indication
Patent ductus arteriosus
Patent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth. Read more about Patent ductus arteriosus
12 drugs 10 manufacturers
Drugs that treat it
Common Patent ductus arteriosus therapies.
NEOPROFEN (IBUPROFEN LYSN)(PF) (ibuprofen lysine/PF)
INDOMETHACIN (indomethacin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPatent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth.
Primarily affecting neonates, with an incidence inversely proportional to gestational age and birth weight, it is particularly prevalent in premature infants.
Persistence of this duct leads to pathological left-to-right shunting of oxygenated blood from the high-pressure systemic circulation into the low-pressure pulmonary circulation.
This hemodynamic alteration produces pulmonary overcirculation, systemic hypoperfusion, and volume overload, clinically manifesting with findings such as a continuous murmur, bounding peripheral pulses, tachypnea, and an increased risk of congestive heart failure.
- nih.gov
Patent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth Persistence of this duct leads to pathological left-to-right shunting of oxygenated blood from the high-pressure systemic circulation into the low-pressure pulmonary circulation
- nih.gov
Patent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth
- nih.gov
Primarily affecting neonates, with an incidence inversely proportional to gestational age and birth weight, it is particularly prevalent in premature infants This hemodynamic alteration produces pulmonary overcirculation, systemic hypoperfusion, and volume overload, clinically manifesting with findings such as a continuous murmur, bounding peripheral pulses, tachypnea, and an increased risk of congestive heart failure
- nih.gov
Persistence of this duct leads to pathological left-to-right shunting of oxygenated blood from the high-pressure systemic circulation into the low-pressure pulmonary circulation This hemodynamic alteration produces pulmonary overcirculation, systemic hypoperfusion, and volume overload, clinically manifesting with findings such as a continuous murmur, bounding peripheral pulses, tachypnea, and an increased risk of congestive heart failure
Personalize your experience
Follow Patent ductus arteriosus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.